These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22956189)

  • 1. D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.
    Jouroukhin Y; Ostritsky R; Gozes I
    J Mol Neurosci; 2012 Nov; 48(3):597-602. PubMed ID: 22956189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N; Pikman R; Giladi E; Gozes I
    Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.
    Jouroukhin Y; Ostritsky R; Assaf Y; Pelled G; Giladi E; Gozes I
    Neurobiol Dis; 2013 Aug; 56():79-94. PubMed ID: 23631872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
    Magen I; Gozes I
    Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).
    Gozes I; Iram T; Maryanovsky E; Arviv C; Rozenberg L; Schirer Y; Giladi E; Furman-Assaf S
    J Alzheimers Dis; 2014; 40 Suppl 1():S23-36. PubMed ID: 24503616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    Ivashko-Pachima Y; Maor-Nof M; Gozes I
    PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
    Gozes I
    Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAP alpha-aminoisobutyric acid (IsoNAP).
    Gozes I; Schirer Y; Idan-Feldman A; David M; Furman-Assaf S
    J Mol Neurosci; 2014 Jan; 52(1):1-9. PubMed ID: 24458740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
    Vulih-Shultzman I; Pinhasov A; Mandel S; Grigoriadis N; Touloumi O; Pittel Z; Gozes I
    J Pharmacol Exp Ther; 2007 Nov; 323(2):438-49. PubMed ID: 17720885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAP (davunetide) provides functional and structural neuroprotection.
    Gozes I
    Curr Pharm Des; 2011; 17(10):1040-4. PubMed ID: 21524250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate.
    Gozes I
    Peptides; 2011 Feb; 32(2):428-31. PubMed ID: 21050875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy.
    Quraishe S; Cowan CM; Mudher A
    Mol Psychiatry; 2013 Jul; 18(7):834-42. PubMed ID: 23587881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Zhao Z; Fu J; Li S; Li Z
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo.
    Chiba T; Hashimoto Y; Tajima H; Yamada M; Kato R; Niikura T; Terashita K; Schulman H; Aiso S; Kita Y; Matsuoka M; Nishimoto I
    J Neurosci Res; 2004 Nov; 78(4):542-52. PubMed ID: 15478191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration.
    Gozes I; Ivashko-Pachima Y
    Front Aging Neurosci; 2015; 7():205. PubMed ID: 26578950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.